Piper Sandler lowered the firm’s price target on Exact Sciences (EXAS) to $60 from $70 following quarterly results. The firm keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXAS:
- Cathie Wood Makes a $69M Bet on Exact Sciences; Sells Palantir, Roblox, and DraftKings
- Exact Sciences Corp’s Strong Earnings Call Highlights
- Exact Sciences: Strong Financial Performance and Strategic Initiatives Justify Buy Rating
- Exact Sciences price target lowered to $66 from $75 at TD Cowen
- EXACT Sciences trading resumes